| 000 | 01203 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250512122335.0 | ||
| 264 | 0 | _c19730710 | |
| 008 | 197307s 0 0 eng d | ||
| 022 | _a0069-0112 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVogel, C L | |
| 245 | 0 | 0 |
_aEffective treatment of Kaposi's sarcoma with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388). _h[electronic resource] |
| 260 |
_bCancer chemotherapy reports _cFeb 1973 |
||
| 300 |
_a65-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmides _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aBlood Cell Count |
| 650 | 0 | 4 |
_aDactinomycin _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRemission, Spontaneous |
| 650 | 0 | 4 |
_aSarcoma, Kaposi _xdrug therapy |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aTriazenes _xadverse effects |
| 700 | 1 | _aPrimack, A | |
| 700 | 1 | _aOwor, R | |
| 700 | 1 | _aKyalwazi, S K | |
| 773 | 0 |
_tCancer chemotherapy reports _gvol. 57 _gno. 1 _gp. 65-71 |
|
| 999 |
_c4707755 _d4707755 |
||